ImmuPharma signs collaboration with Imperial College London
LONDON, UK: ImmuPharma Plc, the specialist drug discovery and development company, has signed a 2-year collaboration agreement with Imperial College London. Under the collaboration, Imperial College will provide significant intellectual input and guidance on a number of innovative peptide assets…